Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Free Cash Flow (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Free Cash Flow came in at $7.3 billion in Q2 2026, up 157.32% year-over-year from $2.8 billion in Q2 2025, and up 397.95% quarter-over-quarter from $1.5 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Free Cash Flow (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Free Cash Flow across 18 years of filings, most recently posting $7.3 billion for Q2 2026.

  • In Q2 2026, Free Cash Flow rose 157.32% year-over-year to $7.3 billion; the TTM figure through Jun 2026 stood at $22.2 billion (up 19.92% YoY), while the FY2025 annual figure was $19.7 billion, down 0.73% from the prior year.
  • Free Cash Flow came in at $7.3 billion for Q2 2026 at Johnson & Johnson, up from $1.5 billion in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $8.0 billion in Q3 2025 to a low of $1.5 billion in Q1 2026.
  • Average Free Cash Flow over 5 years is $4.5 billion, with a median of $4.0 billion recorded in 2024.
  • Year-over-year, Free Cash Flow soared 259.75% in 2023 and plunged 56.64% in 2026.
  • Over 5 years, Free Cash Flow stood at $3.4 billion in 2022, then jumped by 86.06% to $6.3 billion in 2023, then declined by 14.39% to $5.4 billion in 2024, then gained by 1.88% to $5.5 billion in 2025, then surged by 33.32% to $7.3 billion in 2026.
  • Per Business Quant data, the three most recent Free Cash Flow figures were $7.3 billion in Q2 2026, $1.5 billion in Q1 2026, and $5.5 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 7.30 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 3.11 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 6.20 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 302.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 3.09 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 3.44 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -389.61 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 437.80 Mn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn 495.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 7.30 Bn
Mar 29, 2026 1.47 Bn
Dec 28, 2025 5.47 Bn
Sep 28, 2025 8.01 Bn
Jun 29, 2025 2.84 Bn
Mar 30, 2025 3.38 Bn
Dec 29, 2024 5.37 Bn
Sep 29, 2024 6.96 Bn
Jun 30, 2024 4.66 Bn
Mar 31, 2024 2.85 Bn
Dec 31, 2023 6.27 Bn
Oct 1, 2023 6.52 Bn
Jul 2, 2023 3.06 Bn
Apr 2, 2023 2.39 Bn
Jan 1, 2023 1.74 Bn
Apr 3, 2022 3.37 Bn
Oct 3, 2021 7.54 Bn
Jul 4, 2021 4.50 Bn
Apr 4, 2021 3.40 Bn
Jan 3, 2021 7.02 Bn